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agnetic Resonance Imaging
n Patients With Implantable
ardioverter-Defibrillators
nd Pacemakers*
riel Roguin, MD, PHD
aifa, Israel
he number of patients who benefit from cardiovascular
mplantable electronic devices (CIEDs), which include pace-
akers, biventricular pacing devices, and implantable
ardioverter-defibrillators (ICDs), is increasing. This trend is
ikely to continue because of the growing proportion of the
lderly individuals in the population, new indications for heart
ailure therapy, innovative device features, and expanded med-
cal coverage.
See page 549
Compared with other imaging modalities, magnetic reso-
ance imaging (MRI) has many advantages that include its
nparalleled ability to discriminate between different soft tis-
ues and its nonradiation nature. The number of magnetic
esonance (MR) scans that are performed worldwide is also
ncreasing. Although there is no data, it is estimated that at
east 50% of patients with a CIED will probably need to
ndergo MRI over the lifetime of their device as a result of the
ombination of these growing phenomena (1). Thus, in com-
ng years, we will more frequently meet patients with a CIED
ho are referred for an MRI. The American Heart Associa-
ion and the European Society of Cardiology issued statements
n this topic with a detailed strategy for performing MRI in
hese individuals (2,3).
Three types of electromagnetic fields are used to generate an
RI: a constant static magnetic field, a rapidly changing
agnetic gradient field, and a strong radiofrequency field that
s “pulsed” into the body. CIEDs contain ferromagnetic
omponents, complex electrical systems, and leads that are
mplanted into the myocardial tissue. As a result, several
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Department of Cardiology, Rambam Medical Center, B. Rappaport–f
aculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel. Dr.
oguin is a consultant to Medtronic, Minneapolis, Minnesota.otentially hazardous events can occur: movement of the
evice, programming changes, asynchronous pacing, activation
f tachyarrhythmia therapies, inhibition of pacing output, and
nduced lead currents that could lead to cardiac stimulation. In
ddition, heating of the lead tip can result in tissue damage and
hanges in thresholds. This may potentially cause loss of lead
unction. The likelihood that such an event will occur when
erforming MRI in patients with CIEDs has led to concerns.
Indeed, pacemaker and ICD labeling currently cautions
gainst the use of MRI, and MRI manufacturers contraindi-
ate MRI for individuals with a pacemaker or an ICD (1–3).
uring the late 1980s, the death of 10 patients with pacemak-
rs has been attributed to MR procedures. However, these
ases were poorly documented and occurred in the setting of an
R examination that was not supervised or monitored by a
hysician. Most of the previous studies that recommended
gainst MRI in patients with CIEDs were based on in vitro
nd animal data from the 1980s, when older pacemaker and
ead technologies were used.
Advances in device technology were the driving forces to
tudy the interactions between MRI and pacemaker and ICD
ystems in seminal ex vivo and animal studies. The results of
hese studies demonstrated that the devices in use today may be
ore resistant to changes in function during an MR exami-
ation (4). Several groups have measured the effect of MRI on
ead temperature in vivo, and reported only minor stimulation
hreshold changes without any obvious signs that heat-induced
amage occurred (2,4).
In recent years, there have been several prospective human
rials on the relative safety of MR examination at 0.5- to 3.0-T
eld strength. Data on 430 patients who underwent clinically
riven MRI are now available (2,5–7). No deaths have been
eported in physician-supervised MR studies in which the
atients were carefully monitored, although the authors of
hese reports documented a few cases of minor changes in
acing threshold, the need for device reprogramming, and
ossibly battery depletion.
A device may be either MR-safe, which means that it has or
auses no known hazards in all MR environments, or MR-
onditional, which means that the device has been demon-
trated to pose no known hazards in a specified MR environ-
ent with specified conditions of use. Current pacemakers and
CDs are neither MR-safe nor MR-conditional. However, a
acing system (Medtronic EnRhythm-MRI SureScan, Min-
eapolis, Minnesota) was developed and tested specifically for
afe use inMRI. Recently, an international clinical study to test
he safety and efficacy of this prospective newly designed
ual-chamber pacemaker andmodified pacing leads completed
nrollment. The interim analysis was encouraging (8). Accord-
ngly, this device has a European CE-mark, and is the first
R-conditional pacemaker. It is now available commercially
n Europe, and is currently under clinical evaluation in the U.S.
ICDs have more complex technology than pacemakers and
ave larger capacitors and batteries. As a result, the magnetic
orces are greater, and they are theoretically more prone to
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August 4, 2009:556–7 MRI ICDs and Pacemakerslectromagnetic and mechanical interference when a patient
ith an ICD undergoes MRI. Yet, ICDs and pacemakers
hare similar components and software algorithm protection,
nd, thus, to some extent, their responses to interference
uringMR scanningmay be expected to be similar. Laboratory
esting found that modern ICD systems may undergo exten-
ive MR scanning without harm, while older ICDs were
amaged irreversibly (4).
In this issue of the Journal, Naehle et al. (9) report their
xperience with MR scanning of 18 non–pacemaker-
ependent ICD patients with a clinical need for MRI. All
xaminations, which included all body parts, were completed
afely. ICDs could be interrogated and reprogrammed nor-
ally after MRI. There were no increases in serum troponin-I
evels, thereby confirming that no clinically relevant thermal
njury occurred at the ICD lead tips. There were no significant
hanges in pacing parameters. The mean battery voltage
ecreased from pre-MRI 3.86  1.48 V, to post-MRI 3.83 
.48 V but was 3.90  1.52 V at follow-up. None of the
atients reported any torque or heating sensations, or other
nusual symptoms during MRI. The ICD was programmed
o a monitor-only mode, although this may lead to battery
epletion because of false detection of electromagnetic noise
s ventricular fibrillation has occurred in 2 cases. The ICD
hould have been programmed to “detection off” (2,3). No
nexpected changes in heart rate or rhythm occurred. The
uthors conclude that MRI of nonpacemaker-dependent
CD patients can be performed with an acceptable risk-
enefit ratio under controlled conditions by taking both
R- and device-related precautions.
The results of this study contribute to our existing knowl-
dge onMRI in patients with ICDs and confirm the results of
revious reports (2). Gimbel et al. (10) reported their experi-
nce on 7 ICD patients who underwent 8MRI scans at 1.5-T.
o changes in pacing, sensing, impedances, charge times, and
attery status could be demonstrated in all devices after MRI,
nd none of the patients experienced any discomfort during
RI. Nazarian et al. (7) reported their findings on the largest
eported series of patients with ICDs who underwent MRI.
hey scanned 24 patients with ICDs, and reported that all
ere scanned safely. In our institution, we have scanned 8
atients with ICDs in recent years, and all examinations were
neventful.
We must exercise caution, however, given the wide range of
vailable MRI systems, MRI scanning conditions, patient
ositions, pacemaker and ICD systems, and leads when ex-
ending these results to recommendations for routine use of
RI in these patients. The fact that several hundreds of
atients with CIEDs underwent uneventful MRI does not
llow us to conclude thatMRI in this population is indeed safe.
ll published studies were performed at centers with expertise
n MRI and electrophysiology, and were limited to patients
ith a true clinical need forMRI. The number of patients who
xperienced adverse events during and/or after MRI is un-
nown because it has not been reported. KThe diagnostic need for an MR study has to be evaluated
ndividually. Based on current data, it should be done only
hen there is a true necessity and in the absence of an
lternative imaging modality, and the diagnostic benefit from
RI must outweigh the presumed risks (2,3). Faris and Shein
1) from the Food and Drug Administration state, “for some
atients, the risks presented by MRI under specific, character-
zed scanning and monitoring conditions may be acceptable
iven the diagnostic benefit of this powerful imaging modality.”
The risks of MR scanning should be discussed with the
atient, and written informed consent must be obtained before
R scanning. The MR study should be performed at centers
ith expertise in MRI and electrophysiology. The MR scan
hould be optimally planned in order to minimize time and
nergy. A physician who is knowledgeable in device therapy
nd programming should be present during the MR scan.
houghtful pre-MR reprogramming, careful patient monitor-
ng during MR scanning, and thorough follow-up after MR
canning must be performed. Full resuscitation facilities should
e available should any adverse event occur during MR
canning.
MRI may be considered after careful evaluation in se-
ected patients with a CIED, and should only be done when
linically indicated. This may have major implications on
urrent imaging practice (2,3).
eprint requests and correspondence:Dr. Ariel Roguin, Depart-
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